Clinical trial
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in…
NCT00006011 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00006011 |
|---|---|
| Title | Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer |
| Official title | A Randomized Phase III Study of Tumor Volume Directed Pelvic Plus or Minus Para-Aortic Irradiation Followed by Cisplatin and Doxorubicin or Cisplatin, Doxorubicin and Paclitaxel for Advanced Endometrial Carcinoma |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | Eastern Cooperative Oncology Group National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer |
| Intervention type | Biological, Drug |
| Interventions | Doxorubicin Hydrochloride, Cisplatin, Filgrastim, Pegfilgrastim, Paclitaxel |
| Enrollment | 659 |
| Start date | Jul 1, 2000 |
| Primary completion | Mar 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | May 19, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: